Anticonvulsant drugs in primary headaches prophylaxis.

F Frediani

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2005;25 Suppl 3():S161-6

PMID: 15549529

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Anticonvulsant drugs have been used in migraine prophylaxis since 1970. In recent years, new antiepileptic medications have given rise to much interest in pain control. Primary headaches prophylaxis is still based on old drugs, and physicians facing these conditions are always prompted to use any new possible choice. Among primary headaches, the most studied drug over last 15 years was divalproex sodium, and many papers showed its efficacy in the treatment of migraine headaches. Valproate is well tolerated and many dosages have been used with success. For the newer drugs, such as gabapentin, lamotrigine or topiramate, evidence is less strong but has been rapidly increasing in the last 5 years. In particular, topiramate has much more evidence of a good efficacy and a safe profile. We review the principal characteristics of their use, according to dosages, lasting of treatments, side effects and significant efficacy.

Address: Neurological Department, Policlinico S. Pietro, Via Forlanini 15, I-24036 Ponte S. Pietro (BG), Italy. [email protected]

DOI: 10.1007/s10072-004-0278-4

Link outs

Free resources

Medical:

https://medlineplus.gov/headache.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Amines, Anticonvulsants, Carbamazepine, Clinical Trials as Topic, Cyclohexanecarboxylic Acids, Fructose, Gabapentin, Headache, Humans, Isoxazoles, Lamotrigine, Levetiracetam, Oxcarbazepine, Piracetam, Topiramate, Triazines, Valproic Acid, Vigabatrin, Zonisamide, gamma-Aminobutyric Acid